Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Novartis announces FDA approval of its first and only CML therapy with TFR data in product label

Multifunctional protein also plays role in development of blood cells

Multifunctional protein also plays role in development of blood cells

Clinical benefit of new cancer therapies may justify the expensive price

Clinical benefit of new cancer therapies may justify the expensive price

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Scientists develop test to predict treatment outcomes in patients with childhood leukemia

Researchers reveal previously unknown mechanism that inhibits cells' ability to develop into tumors

Researchers reveal previously unknown mechanism that inhibits cells' ability to develop into tumors

Transfusion dependence reduces access to high-quality end-of-life care for leukemia patients

Transfusion dependence reduces access to high-quality end-of-life care for leukemia patients

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study reveals novel molecular targets to improve chemotherapy’s efficiency against leukemia

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Scientists develop software that predicts leukemia-specific immune targets

Scientists develop software that predicts leukemia-specific immune targets

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

St. Jude gene therapy offers hope for infants with 'bubble boy' disease

St. Jude gene therapy offers hope for infants with 'bubble boy' disease

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Drug improves disease-free, overall survival after hematopoietic stem cell transplants

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

High ADAR1 enzyme levels correlate with reduced survival rates in multiple myeloma

OICR announces innovative initiative to drive development of new cancer therapies

OICR announces innovative initiative to drive development of new cancer therapies

UC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatments

UC San Diego researchers receive nearly $8 million grant for new stem cell-based AML treatments